Antibody Effective at Blocking Coronavirus from Human Cells: Sorrento Therapeutics
2:47
Antibody Effective at Blocking Coronavirus from Human Cells: Sorrento Therapeutics
May 15, 2020
nbcsandiego.com
Sorrento Therapeutics gets FDA approval for COVID-19 drug trial
2:49
Sorrento Therapeutics gets FDA approval for COVID-19 drug trial
Jul 21, 2020
YahooYahoo Finance Video
Sorrento Therapeutics' Next-Generation COVID-19 Therapeutic Antibody | The Motley Fool
Sorrento Therapeutics' Next-Generation COVID-19 Therapeutic Antibody | The Motley Fool
Nov 21, 2020
fool.com
L'essai de phase avancée sur la sciatique de Sorrento Therapeutics Unit répond aux critères d'efficacité.
L'essai de phase avancée sur la sciatique de Sorrento Therapeutics Unit répond aux critères d'efficacité.
Dec 9, 2021
zonebourse.com
Sorrento Therapeutics Pain Therapy TV Spot
Sorrento Therapeutics Pain Therapy TV Spot
Aug 7, 2014
iSpot.tv
Sorrento Therapeutics CEO talks moving Abivertinib into Phase 2 trial for Covid-19
2:53
Sorrento Therapeutics CEO talks moving Abivertinib into Phase 2 trial for Covid-19
Jul 21, 2020
CNBC
Sorrento Therapeutics Signs Exclusive Licensing Deal with Mabtech
Sorrento Therapeutics Signs Exclusive Licensing Deal with Mabtech
Aug 3, 2015
marketscreener.com
Sorrento Shares Double on Claim of a Potential Breakthrough Virus Drug
Sorrento Shares Double on Claim of a Potential Breakthrough Virus Drug
May 15, 2020
thestreet.com
Sorrento Therapeutics CEO: Start of human trials for our coronavirus drug are 'two to three months away'
7:42
Sorrento Therapeutics CEO: Start of human trials for our coronavirus drug are 'two to three months away'
Jun 9, 2020
CNBC
Sorrento Therapeutics, Inc. publie les données non aveugles de l'étude de phase 1B de son inhibiteur oral de la protéase virale principale, OVYDSO™ (STI-1558) chez les patients atteints de Covid
Sorrento Therapeutics, Inc. publie les données non aveugles de l'étude de phase 1B de son inhibiteur oral de la protéase virale principale, OVYDSO™ (STI-1558) chez les patients atteints de Covid
Jan 9, 2023
zonebourse.com
Sorrento Therapeutics' Slow-But-Steady Approach to COVID-19 | The Motley Fool
Sorrento Therapeutics' Slow-But-Steady Approach to COVID-19 | The Motley Fool
Nov 22, 2020
fool.com
Sorrento Therapeutics on the company's Covid-19 saliva test
6:36
Sorrento Therapeutics on the company's Covid-19 saliva test
Aug 4, 2020
CNBC
Sorrento Therapeutics CEO on focusing on ‘the real deal’ antibody test rather than stock performance
6:33
Sorrento Therapeutics CEO on focusing on ‘the real deal’ antibody test rather than stock performance
May 20, 2020
YahooYahoo Finance Video
Sorrento CEO discusses the latest on its coronavirus antibody treatment and rapid saliva test
7:26
$
Sorrento CEO discusses the latest on its coronavirus antibody treatment and rapid saliva test
Oct 15, 2020
CNBC
Sorrento Therapeutics CEO Henry Ji on potential Covid-19 antibody
5:38
Sorrento Therapeutics CEO Henry Ji on potential Covid-19 antibody
May 18, 2020
CNBC
Sorrento Therapeutics CEO details Covishield neutralizing antibody
7:38
Sorrento Therapeutics CEO details Covishield neutralizing antibody
Feb 2, 2022
YahooYahoo Finance Video
Sorrento Therapeutics Reports Promising Data From an Uncontrolled Clinical Trial | The Motley Fool
Sorrento Therapeutics Reports Promising Data From an Uncontrolled Clinical Trial | The Motley Fool
Feb 12, 2021
fool.com
Oversold Conditions For Sorrento Therapeutics (SRNE)
Oversold Conditions For Sorrento Therapeutics (SRNE)
Dec 3, 2021
nasdaq.com
Sorrento Therapeutics | Sofusa DoseConnect Training for Clinical Trials
2:22
Sorrento Therapeutics | Sofusa DoseConnect Training for Clinical Trials
479 viewsSep 18, 2019
VimeoECG Productions
Stocks on the move: Sorrento on FDA approval of COVID drug, Moderna on slower timeline for vaccine
1:04
Stocks on the move: Sorrento on FDA approval of COVID drug, Moderna on slower timeline for vaccine
Sep 17, 2020
YahooYahoo Finance Video
Sorrento Therapeutics, Inc. Emerged from Bankruptcy
Sorrento Therapeutics, Inc. Emerged from Bankruptcy
Apr 9, 2024
marketscreener.com
In-Depth: San Diego company developing nasal drops to treat COVID
2:55
In-Depth: San Diego company developing nasal drops to treat COVID
1K viewsJan 21, 2022
YahooKGTV - San Diego Scripps
Sorrento Therapeutics CEO discusses new antibody test to detect COVID-19
6:51
Sorrento Therapeutics CEO discusses new antibody test to detect COVID-19
8.1K viewsMay 20, 2020
YouTubeYahoo Finance
Sorrento Therapeutics CEO talks moving Abivertinib into Phase 2 trial for Covid-19
3:07
Sorrento Therapeutics CEO talks moving Abivertinib into Phase 2 trial for Covid-19
15K viewsJul 21, 2020
YouTubeCNBC Television
Sorrento Therapeutics Sued Over ‘False' Claims About Finding ‘Cure' for COVID-19, Lawsuit Says
Sorrento Therapeutics Sued Over ‘False' Claims About Finding ‘Cure' for COVID-19, Lawsuit Says
Jun 12, 2020
nbcsandiego.com
Sorrento Therapeutics CEO: Human trials for Covid-19 drug are 'two to three months away'
7:56
Sorrento Therapeutics CEO: Human trials for Covid-19 drug are 'two to three months away'
23.4K viewsJun 9, 2020
YouTubeCNBC Television
MSN
0:43
MSN
Oct 10, 2024
MSNChristina-Lauren Pollack - Inspirations and Cel…
Sorrento STI-6129 ADC Initial Human Study Update 02/20/2021
11:56
Sorrento STI-6129 ADC Initial Human Study Update 02/20/2021
803 viewsMar 10, 2021
YouTubeAmyloidosis Support Groups
Sorrento Says Its Virus Antibody Cocktail Works
5:34
Sorrento Says Its Virus Antibody Cocktail Works
5.6K viewsMay 22, 2020
YouTubeBloomberg Technology
Seating Matters Sorrento 2 Chair
1:56
Seating Matters Sorrento 2 Chair
5.3K viewsMay 16, 2023
YouTubeSeating Matters
See more